Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -7.33%10.17K | -49.47%14.82K | 168.18%20.04K | 48.60%58.94K | 19.48%11.17K | -16.46%10.98K | 315.46%29.33K | -26.19%7.47K | 123.32%39.67K | 108.08%9.35K |
| Gross profit | 7.33%-10.17K | 49.47%-14.82K | -168.18%-20.04K | -48.60%-58.94K | -19.48%-11.17K | 16.46%-10.98K | -315.46%-29.33K | 26.19%-7.47K | -123.32%-39.67K | -108.08%-9.35K |
| Operating expense | -41.67%492.43K | 180.87%673.84K | 168.26%874.71K | 4.24%1.94M | 12.47%521.92K | 80.78%844.27K | -35.41%239.91K | -36.93%326.07K | -52.11%1.86M | -11.96%464.05K |
| Selling and administrative expenses | -41.94%470.59K | 213.00%645.82K | 179.36%840.27K | 5.72%1.82M | 16.24%487.36K | 97.37%810.53K | -42.74%206.33K | -37.73%300.78K | -52.67%1.72M | -22.04%419.26K |
| -General and administrative expense | -41.94%470.59K | 213.00%645.82K | 179.36%840.27K | 5.72%1.82M | 16.24%487.36K | 97.37%810.53K | -42.74%206.33K | -37.73%300.78K | -52.67%1.72M | -22.04%419.26K |
| Research and development costs | -35.28%21.84K | -16.55%28.02K | 36.16%34.43K | -13.05%127.17K | -22.85%34.56K | -40.13%33.74K | 201.47%33.58K | -25.55%25.29K | -44.39%146.26K | 520.24%44.8K |
| Operating profit | 41.23%-502.6K | -155.78%-688.66K | -168.26%-894.74K | -5.17%-2M | -12.61%-533.09K | -78.12%-855.25K | 28.87%-269.24K | 36.72%-333.54K | 51.31%-1.9M | 10.95%-473.4K |
| Net non-operating interest income (expenses) | 10,722.61%28.25K | 738.92%26.51K | -99.80%15 | -74.57%2.88K | -267.32%-8.14K | -76.94%261 | 370.24%3.16K | 63.77%7.59K | -45.25%11.31K | 190.68%4.87K |
| Non-operating interest income | 10,722.61%28.25K | 738.92%26.51K | -99.80%15 | -46.82%11.47K | -96.99%456 | -76.94%261 | 370.24%3.16K | 63.77%7.59K | -22.14%21.57K | 796.21%15.13K |
| Non-operating interest expense | ---- | ---- | ---- | -16.24%8.6K | ---- | ---- | ---- | ---- | 45.51%10.26K | ---- |
| Other net income (expenses) | 274.05%72.25K | 98.90%-56.39K | 782.17%172.98K | -19,320.31%-5.15M | -25.62%3.26K | 18.66%-41.51K | -38,547.73%-5.13M | 188.65%19.61K | 98.04%-26.52K | 100.29%4.38K |
| Gain on sale of security | 274.05%72.25K | -1,947.61%-56.39K | 782.17%172.98K | -23.99%-15.6K | 157.88%3.26K | 18.66%-41.51K | -91.82%3.05K | 188.65%19.61K | -106.66%-12.58K | -149.42%-5.62K |
| Special income (charges) | --0 | --0 | ---- | -36,728.80%-5.13M | --0 | --0 | -21,346.29%-5.13M | ---- | 99.10%-13.94K | 100.65%10K |
| -Less:Impairment of capital assets | --0 | --0 | ---- | --5.13M | --0 | --0 | --5.13M | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---10K | ---- |
| -Less:Write off | ---- | ---- | ---- | ---- | ---- | --0 | --5.13M | ---- | --0 | --0 |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | ---23.94K | --0 |
| Income before tax | 55.15%-402.1K | 86.69%-718.54K | -135.60%-721.75K | -272.57%-7.15M | -15.90%-537.97K | -69.13%-896.5K | -1,380.88%-5.4M | 40.59%-306.34K | 63.39%-1.92M | 77.55%-464.16K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 55.15%-402.1K | 86.69%-718.54K | -135.60%-721.75K | -272.57%-7.15M | -15.90%-537.97K | -56.02%-896.5K | -1,380.88%-5.4M | 40.59%-306.34K | 63.39%-1.92M | 77.55%-464.16K |
| Net income continuous operations | 55.15%-402.1K | 86.69%-718.54K | -135.60%-721.75K | -272.57%-7.15M | -15.90%-537.97K | -56.02%-896.5K | -1,380.88%-5.4M | 40.59%-306.34K | 63.39%-1.92M | 77.55%-464.16K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 55.15%-402.1K | 86.69%-718.54K | -135.60%-721.75K | -272.57%-7.15M | -15.90%-537.97K | -56.02%-896.5K | -1,380.88%-5.4M | 40.59%-306.34K | 63.39%-1.92M | 77.55%-464.16K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 55.15%-402.1K | 86.69%-718.54K | -135.60%-721.75K | -272.57%-7.15M | -15.90%-537.97K | -56.02%-896.5K | -1,380.88%-5.4M | 40.59%-306.34K | 63.39%-1.92M | 77.55%-464.16K |
| Diluted earnings per share | 0 | 80.00%-0.01 | 0.00%-0.01 | -200.00%-0.06 | 0 | 0.00%-0.01 | -1,091.61%-0.05 | 0.00%-0.01 | 71.43%-0.02 | 66.67%-0.01 |
| Basic earnings per share | 0 | 80.00%-0.01 | 0.00%-0.01 | -200.00%-0.06 | 0 | 0.00%-0.01 | -1,091.61%-0.05 | 0.00%-0.01 | 71.43%-0.02 | 66.67%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.